Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Nanjing Leads Biolabs Co., Ltd. Class H ( (HK:9887) ) has provided an announcement.
Nanjing Leads Biolabs Co., Ltd. has announced its inclusion in the MSCI Global Small Cap Indexes, effective after market close on November 24, 2025. This inclusion is seen as a recognition of the company’s operating performance and development potential by global investors, potentially enhancing its visibility and attractiveness to international investment institutions.
The most recent analyst rating on (HK:9887) stock is a Buy with a HK$80.27 price target. To see the full list of analyst forecasts on Nanjing Leads Biolabs Co., Ltd. Class H stock, see the HK:9887 Stock Forecast page.
More about Nanjing Leads Biolabs Co., Ltd. Class H
Nanjing Leads Biolabs Co., Ltd. is a joint stock company based in the People’s Republic of China, operating in the biotechnology sector. The company focuses on developing innovative solutions and has a market presence that attracts international investment interest.
Average Trading Volume: 845,124
Current Market Cap: HK$11.13B
For a thorough assessment of 9887 stock, go to TipRanks’ Stock Analysis page.